Technical Analysis for NRXS - Neuraxis, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 3.35 | -6.94% | -0.25 |
NRXS closed down 6.94 percent on Friday, September 22, 2023, on 57 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | -6.94% | |
| Inside Day | Range Contraction | -6.94% | |
| Wide Bands | Range Expansion | -6.94% | |
| Lower Bollinger Band Touch | Weakness | -6.94% | |
| Oversold Stochastic | Weakness | -6.94% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 3 days ago |
| New 52 Week Low | 3 days ago |
| Down 10% | 3 days ago |
| Lower Bollinger Band Support | 3 days ago |
| Fell Below Lower Bollinger Band | 3 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. NeurAxis, Inc. was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is based in Versailles, Indiana.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pain Neuromodulation Abdominal Pain Neurophysiology Neurotechnology Neuropsychology Irritable Bowel Syndrome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pain Neuromodulation Abdominal Pain Neurophysiology Neurotechnology Neuropsychology Irritable Bowel Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.93 |
| 52 Week Low | 3.19 |
| Average Volume | 42,187 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 4.24 |
| 10-Day Moving Average | 4.07 |
| Average True Range | 0.74 |
| RSI (14) | 35.48 |
| ADX | 20.29 |
| +DI | 11.81 |
| -DI | 23.09 |
| Chandelier Exit (Long, 3 ATRs) | 3.79 |
| Chandelier Exit (Short, 3 ATRs) | 5.41 |
| Upper Bollinger Bands | 5.25 |
| Lower Bollinger Band | 3.24 |
| Percent B (%b) | 0.06 |
| BandWidth | 47.36 |
| MACD Line | -0.47 |
| MACD Signal Line | -0.41 |
| MACD Histogram | -0.0623 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.34 | ||||
| Resistance 3 (R3) | 4.40 | 4.12 | 4.18 | ||
| Resistance 2 (R2) | 4.12 | 3.87 | 4.10 | 4.12 | |
| Resistance 1 (R1) | 3.74 | 3.72 | 3.60 | 3.68 | 4.06 |
| Pivot Point | 3.46 | 3.46 | 3.40 | 3.44 | 3.46 |
| Support 1 (S1) | 3.08 | 3.21 | 2.94 | 3.02 | 2.64 |
| Support 2 (S2) | 2.80 | 3.06 | 2.78 | 2.58 | |
| Support 3 (S3) | 2.42 | 2.80 | 2.53 | ||
| Support 4 (S4) | 2.36 |
